diphenhydramine has been researched along with Lip Diseases in 1 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Lip Diseases: Diseases involving the LIP.
Excerpt | Relevance | Reference |
---|---|---|
"Psoriasis is a chronic immune-mediated disease of unknown etiology that affects the skin and mucous membranes." | 1.38 | Oral manifestations of psoriasis. Clinical presentation and management. ( Brown, GC; Dreyer, LN, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dreyer, LN | 1 |
Brown, GC | 1 |
1 other study available for diphenhydramine and Lip Diseases
Article | Year |
---|---|
Oral manifestations of psoriasis. Clinical presentation and management.
Topics: Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2012 |